Maverick Capital, Ltd. 13D and 13G filings for Atara Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 5:03 pm Sale | 2023-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA | Maverick Capital, Ltd. | 0 0.000% | -251,641 (Position Closed) | Filing |
| 2023-02-14 07:31 am Sale | 2022-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA | Maverick Capital, Ltd. | 251,641 6.600% | -62,592 (-19.92%) | Filing |
| 2022-03-11 5:05 pm Purchase | 2021-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA | Maverick Capital, Ltd. | 314,233 8.400% | 21,251 (+7.25%) | Filing |
| 2021-02-16 1:41 pm Purchase | 2020-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA | Maverick Capital, Ltd. | 292,982 8.900% | 94,644 (+47.72%) | Filing |